Drug recall · April 12, 2017
Fluphenazine Decanoate Injection recall
Why: Subpotent Drug
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-0272-05
- Lots / codes
Lot #: 6111141, Exp. 07/17; 6111222, Exp. 08/17; 6112346, Exp. 01/18; 6112725, Exp. 03/18
- Quantity
- 118,224 vials
- Company
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Distribution
- Nationwide within the US
- Initiated
- March 16, 2017 · Voluntary: Firm initiated
- Classified
- April 5, 2017
- Reported
- April 12, 2017
- Ended
- August 28, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fluphenazine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.